December 22, 2024 - 18:22

BRATTLEBORO — A finance committee is urging the Select Board to request a list of potential staff cuts from town employees as discussions about the municipal budget heat up. The committee's recommendation comes in light of concerns that the proposed budget may see a significant increase, prompting the need for careful examination of expenditures.
Committee members emphasized the importance of fiscal responsibility, suggesting that identifying possible reductions in personnel could help alleviate the financial strain on the town's budget. The committee's discussions underscore the balancing act of maintaining essential services while managing costs effectively.
Town officials are expected to deliberate on the committee's suggestion in upcoming meetings. The outcome of these discussions could have lasting implications for the town's workforce and its ability to deliver services to residents. As the budget process unfolds, community members are encouraged to stay informed and engaged in the decision-making process.
March 28, 2026 - 08:16
Upstate woman charged with insurance fraud and financial identity theftAn Upstate woman has been arrested and charged with insurance fraud and financial identity theft following an investigation into a suspicious vehicle damage claim. According to arrest warrants, the...
March 27, 2026 - 21:27
Social Media Giants Face Market Pressure Following Legal SetbackShares of major social media companies extended their losses on Friday, as investors continued to digest the financial and regulatory implications of a recent legal defeat. The sell-off reflects...
March 27, 2026 - 00:26
NDSU College of Business launches Center for Banking and FinanceA new hub dedicated to the financial sector has officially opened its doors, aiming to bridge the gap between academic theory and real-world practice. The recently launched Center for Banking and...
March 26, 2026 - 05:08
Precigen Reports Full Year 2025 Financial Results and Business UpdatesPrecigen, Inc. has officially transitioned into a commercial-stage biotechnology company, marking a transformative year in 2025. This shift follows the landmark US approval of PAPZIMEOS™...